Trial Profile
Effects of atorvastatin on thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2011
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Atorvastatin (Primary)
- Indications Embolism and thrombosis; Hypercholesterolaemia; Peripheral arterial occlusive disorders
- Focus Pharmacodynamics
- 14 Jul 2011 New trial record
- 26 May 2011 Results published in Thrombosis and Haemostasis.